Operational Excellence Lead: BioVectra

Description

BioVectra, now part of Agilent’s Advanced Therapeutics Division (ATD), is a CDMO producing active pharmaceutical ingredients at clinical-to-commercial scale across microbial fermentation, small molecules, plasmid DNA, mRNA, LNP, and sterile fill, operating from Charlottetown, PEI and Windsor, Nova Scotia. This posting is for the BioVectra assignment within Agilent's Operational Excellence (OEx) function.

Agilent’s Operational Excellence function builds and embeds the production system on the manufacturing floor. The function exists to convert operational performance into capacity the divisions can sell. The Operational Excellence Lead owns this build across the full value stream, from fermentation through downstream recovery and purification to release-readiness and leads through depth of expertise with no direct reports. Success depends on influence through the ATD OEX governance model: site leadership owns operating results, while this role o...